Skip to search formSkip to main contentSkip to account menu

naftopidil

Known as: 1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (6)

Adrenergic alpha-AntagonistsAntihypertensive AgentsCalcium Channel BlockersNaphthalenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Effects of an alpha1A/D‐adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury
In order to clarify whether an alpha1A/D‐adrenoceptor (α1A/D‐AR) antagonist, naftopidil, or a phosphodiesterase type 5 (PDE5… 
2016
2016
Propiverine increases urethral wall catecholamine levels and bladder leak point pressure in rats
To investigate whether propiverine has a noradrenaline re‐uptake inhibitor and whether it acts on the lumbosacral cord or the… 
2013
2013
Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat
As increasing evidence suggest that α1‐blockers prevent benign prostatic hyperplasia related overactive bladder and nocturia in… 
2009
2009
Prostate growth inhibition by subtype‐selective alpha1‐adrenoceptor antagonist naftopidil in benign prostatic hyperplasia
Recently, alpha1‐adrenoceptors (α1‐ARs) have been reported to play a prominent role in the growth of a variety of cells; however… 
2008
2008
In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
2007
2007
Short-term efficacy and long-term compliance/treatment failure of the α1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
Objective. To evaluate treatment failure during a 4-year follow-up period after administration of naftopidil for patients with… 
2006
2006
Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure.
2006
2006
Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
AIM We evaluated the efficacy of an alpha1a/d blocker, naftopidil, on storage symptoms in patients with benign prostatic… 
1991
1991
[3H]bunazosin, a novel selective radioligand of alpha 1 adrenoceptors in human prostates.
1991
1991
Characterization of Ca2+-Antagonistic Effects of Three Metabolites of the New Antihypertensive Agent Naftopidil, (naphthyl)Hydroxy‐Naftopidil, (phenyl)Hydroxy‐Naftopidil and O-Desmethyl‐Naftopidil
The newly developed antihypertensive agent naftopidil blocks α1-adrenoceptors and inhibits Ca2+ entry via potential-dependent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)